Type 2 Diabetes Treatment for Diverse Populations: Integrating New and Emerging Agents
 
Release Date: July 29, 2014
Last Reviewed: July 10, 2014
Expiration Date: July 29, 2015
Time to Complete Activity:  2.0 hours
 
This activity is sponsored by Global Education Group.  Paradigm Medical Communications, LLC is the educational partner.


 

 

Faculty
Vivian Fonseca, MD – Moderator and Program Chair
Professor of Medicine and Pharmacology
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
New Orleans, LA
 
Joseph R. Betancourt, MD, MPH
Director, The Disparities Solutions Center
Senior Scientist, The Mongan Institute for Health Policy
Director of Multicultural Education
Multicultural Affairs Office, Massachusetts General Hospital
Associate Professor of Medicine, Harvard Medical School
Boston, MA
 
Samuel Dagogo-Jack, MD
A.C. Mullins Professor in Translational Research
Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism
Director, General Clinical Research Center
University of Tennessee Health Science Center
Memphis, TN
 
Allison B. Goldfine, MD
Associate Professor
Harvard Medical School
Head, Section of Clinical Research
Joslin Diabetes Center
Boston, MA
 
Target Audience
The educational design of this activity addresses the needs of physicians specializing in endocrinology, internal medicine, cardiology, and family practice, as well as allied healthcare practitioners.  This activity will also be of benefit to other HCPs interested in the management of patients with diabetes.
 
Statement of Need
Type 2 diabetes disproportionately affects ethnic minorities. Nonwhite populations have greater susceptibility to the disease, and Hispanic and African American patients often have poorer outcomes than their white counterparts, leading to increased healthcare utilization costs (eg, more hospitalizations). The elderly are also more vulnerable to diabetes-related risks. Disparities in type 2 diabetes arise from various genetic, cultural, and socioeconomic differences, but can be successfully overcome by approaches that put the patient at the center of the management effort. Treatments should be selected based on the individual patient’s profile and risk of adverse events and complications, with consideration of the costs of these sequelae as well as the cost of medications. Medical comorbidities such as obesity, hypertension, renal disease, and cardiovascular disease should also be considered. Diabetologists and diabetes educators provide guidance in their communities to both patients and other healthcare providers. This leadership role requires mastery of the benefits and limitations of the many different antihyperglycemic therapies for patients with various comorbid conditions. In addition, awareness of approaches that have improved outcomes in underserved populations is vital to improving the overall well-being of patients with type 2 diabetes.
 
Learning Objectives
Upon proper completion of this activity, participants should be better able to:
  • Explain the consequences of inadequate diabetes management across diverse patient populations.
  • Differentiate among the 2 types of incretin-based therapies and SGLT2 inhibitors.
  • Describe the extraglycemic effects of incretin-based therapies and SGLT2 inhibitors.
Agenda
Clinical Program
  • Treatment Decision-Making for Diverse and Specialized Patient Populations
  • Incretin-Based Therapies and SGLT2 Inhibitors: Where Do They Fit Within an Individualized Treatment Plan?
  • Extraglycemic Effects of Recently Developed Pharmacotherapy
  • Case Discussion/Q&A
Physician Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Physician Credit Designation Statement
Global Education Group designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Physician Assistant Continuing Education
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 2 hours of Category 1 credit for completing this program.
 
Nurse Practitioner Continuing Education

Global Education Group is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners: AANP Provider Number 1101021. This program has been approved for 2.0 contact hours of continuing education (which includes 1.0 hours of pharmacology).
 
Disclosure of Commercial Support
This CME activity is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc., which was made possible, in part, through collaboration with Eli Lilly and Company.
 
Instructions for Participation
To receive CME certificate of participation, participants should:
  • Follow instructions to register or log in with your professional information and complete the pre-activity assessment.
  • View the online activity in its entirety.
  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest.
  • A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.
 There is no fee required for participation in this activity.

Hardware/Software Requirements
This certified CME activity is designed as a self-running Flash presentation. In the event that you need this plug-in, a link to download the required Flash Player has been provided below.
 
Flash Player 10 or later required–download at http://www.adobe.com/support/flashplayer/downloads.html
 
For your convenience, a control bar is located at the bottom of the screen that provides buttons to move forward and backward through the deck. 
 
Supported Browsers:
For Windows: Internet Explorer 7 or higher, Firefox 4.0, Safari 3, Google Chrome, Opera 9.5
For Mac: Safari 3, Firefox 4.0, Google Chrome
Linux: Firefox 4.0
 
Technical Support: If you have any technical problems or playback issues, please click on the Technical Support button on the left of the screen or call 845-398-5100.
 
Disclosure of Conflicts of Interest
Global Education Group (Global) and Paradigm Medical Communications, LLC (Paradigm) requires instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity.  All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. 
 
Faculty
Vivian Fonseca, MD
Consultant: GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Novo Nordisk A/S; Sanofi-Aventis US, LLC; Eli Lilly and Company; Daiichi Sankyo Company, Limited; Pamlab, Inc; AstraZeneca plc; Abbott Laboratories; Bristol-Myers Squibb Company; Boehringer Ingelheim Pharmaceuticals, Inc; Janssen Pharmaceuticals, Inc
Research Support: Novo Nordisk A/S; Sanofi-Aventis US, LLC; Eli Lilly and Company; Abbott Laboratories; Pan American Labs LLC; Reata Pharmaceuticals, Inc; GI Dynamics, Inc; Asahi Kasei Pharma America

Joseph R. Betancourt, MD, MPH
No commercial relationships to disclose
 
Samuel Dagogo-Jack, MD
Consultant: Merck & Co; Novo Nordisk A/S; Janssen Pharmaceuticals, Inc
Contracted Research: AstraZeneca plc, Novo Nordisk A/S, Boehringer Ingelheim Pharmaceuticals, Inc
 
Allison B. Goldfine, MD
Consultant: Novo Nordisk A/S
Research Support:Daiichi Sankyo Company, Limited
Support for NIH-sponsored trials: Caraco Pharmaceutical Laboratories, LTD; Amneal Pharmaceuticals LLC; Lifescan, Inc; Novo Nordisk A/S; Nestle USA; Mercodia AB
 
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
 
Name of Planner or Manager
Reported Financial Relationship
Ashley Marostica, RN, MSN
Nothing to disclose
Amanda Glazer, PhD
Nothing to disclose
Amanda Hodges
Nothing to disclose
Andrea Funk
Nothing to disclose
 
Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.
 
Independent peer reviewer has no financial relationships to disclose.
 
Resolution of Conflict of Interest
Global Education Group and Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, independent, fairly balanced, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity has been independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.
 
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA.
 
Disclaimer
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Global Education Group or Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
 
Signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.
 
Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Global Education Group or Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Global Education Group or Paradigm Medical Communications, LLC. Global Education Group and Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.
 
Privacy policy
Global Education Group and Paradigm Medical Communications, LLC is committed to protecting the privacy of those who participate in the activities (herein referred to as "website") located at www.paradigmmc.com. The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.
 
Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.
 
Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Global Education Group and Paradigm Medical Communications, LLC to continuously improve the learning experience.
 
Global Education Group and Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Global Education Group and Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Global Education Group and Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.
 
Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com.
 
© 2014 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.